1
|
Lerner A, Benzvi C, Vojdani A. SARS-CoV-2 Gut-Targeted Epitopes: Sequence Similarity and Cross-Reactivity Join Together for Molecular Mimicry. Biomedicines 2023; 11:1937. [PMID: 37509576 PMCID: PMC10376948 DOI: 10.3390/biomedicines11071937] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2023] [Revised: 07/02/2023] [Accepted: 07/06/2023] [Indexed: 07/30/2023] Open
Abstract
The gastrointestinal tract can be heavily infected by SARS-CoV-2. Being an auto-immunogenic virus, SARS-CoV-2 represents an environmental factor that might play a role in gut-associated autoimmune diseases. However, molecular mimicry between the virus and the intestinal epitopes is under-investigated. The present study aims to elucidate sequence similarity between viral antigens and human enteric sequences, based on known cross-reactivity. SARS-CoV-2 epitopes that cross-react with human gut antigens were explored, and sequence alignment was performed against self-antigens implicated in enteric autoimmune conditions. Experimental SARS-CoV-2 epitopes were aggregated from the Immune Epitope Database (IEDB), while enteric antigens were obtained from the UniProt Knowledgebase. A Pairwise Local Alignment tool, EMBOSS Matcher, was employed for the similarity search. Sequence similarity and targeted cross-reactivity were depicted between 10 pairs of immunoreactive epitopes. Similar pairs were found in four viral proteins and seven enteric antigens related to ulcerative colitis, primary biliary cholangitis, celiac disease, and autoimmune hepatitis. Antibodies made against the viral proteins that were cross-reactive with human gut antigens are involved in several essential cellular functions. The relationship and contribution of those intestinal cross-reactive epitopes to SARS-CoV-2 or its potential contribution to gut auto-immuno-genesis are discussed.
Collapse
Affiliation(s)
- Aaron Lerner
- Chaim Sheba Medical Center, The Zabludowicz Research Center for Autoimmune Diseases, Ramat Gan 52621, Israel
- Research Department, Ariel University, Ariel 40700, Israel
| | - Carina Benzvi
- Chaim Sheba Medical Center, The Zabludowicz Research Center for Autoimmune Diseases, Ramat Gan 52621, Israel
| | | |
Collapse
|
2
|
Reid LM, Guzzetti I, Svensson T, Carlsson AC, Su W, Leek T, von Sydow L, Czechtizky W, Miljak M, Verma C, De Maria L, Essex JW. How well does molecular simulation reproduce environment-specific conformations of the intrinsically disordered peptides PLP, TP2 and ONEG? Chem Sci 2022; 13:1957-1971. [PMID: 35308859 PMCID: PMC8848758 DOI: 10.1039/d1sc03496k] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2021] [Accepted: 01/03/2022] [Indexed: 12/31/2022] Open
Abstract
Understanding the conformational ensembles of intrinsically disordered proteins and peptides (IDPs) in their various biological environments is essential for understanding their mechanisms and functional roles in the proteome, leading to a greater knowledge of, and potential treatments for, a broad range of diseases. To determine whether molecular simulation is able to generate accurate conformational ensembles of IDPs, we explore the structural landscape of the PLP peptide (an intrinsically disordered region of the proteolipid membrane protein) in aqueous and membrane-mimicking solvents, using replica exchange with solute scaling (REST2), and examine the ability of four force fields (ff14SB, ff14IDPSFF, CHARMM36 and CHARMM36m) to reproduce literature circular dichroism (CD) data. Results from variable temperature (VT) 1H and Rotating frame Overhauser Effect SpectroscopY (ROESY) nuclear magnetic resonance (NMR) experiments are also presented and are consistent with the structural observations obtained from the simulations and CD. We also apply the optimum simulation protocol to TP2 and ONEG (a cell-penetrating peptide (CPP) and a negative control peptide, respectively) to gain insight into the structural differences that may account for the observed difference in their membrane-penetrating abilities. Of the tested force fields, we find that CHARMM36 and CHARMM36m are best suited to the study of IDPs, and accurately predict a disordered to helical conformational transition of the PLP peptide accompanying the change from aqueous to membrane-mimicking solvents. We also identify an α-helical structure of TP2 in the membrane-mimicking solvents and provide a discussion of the mechanistic implications of this observation with reference to the previous literature on the peptide. From these results, we recommend the use of CHARMM36m with the REST2 protocol for the study of environment-specific IDP conformations. We believe that the simulation protocol will allow the study of a broad range of IDPs that undergo conformational transitions in different biological environments.
Collapse
Affiliation(s)
- Lauren M Reid
- School of Chemistry, University of Southampton Highfield Southampton SO17 1BJ UK
- Bioinformatics Institute (ASTAR) 30 Biolpolis Street Matrix 138671 Singapore
- MedChemica Ltd Alderley Park Macclesfield Cheshire SK10 4TG UK
| | - Ileana Guzzetti
- Medical Chemistry, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden
| | - Tor Svensson
- Medical Chemistry, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden
| | - Anna-Carin Carlsson
- Early Chemical Development, Pharmaceutical Sciences, BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden
| | - Wu Su
- Medical Chemistry, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden
| | - Tomas Leek
- Medical Chemistry, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden
| | - Lena von Sydow
- Medical Chemistry, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden
| | - Werngard Czechtizky
- Medical Chemistry, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden
| | - Marija Miljak
- School of Chemistry, University of Southampton Highfield Southampton SO17 1BJ UK
| | - Chandra Verma
- Bioinformatics Institute (ASTAR) 30 Biolpolis Street Matrix 138671 Singapore
- Department of Biological Sciences, National University of Singapore 16 Science Drive 4 117558 Singapore
- School of Biological Sciences, Nanyang Technological University 60 Nanyang Dr 637551 Singapore
| | - Leonardo De Maria
- Medical Chemistry, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden
| | - Jonathan W Essex
- School of Chemistry, University of Southampton Highfield Southampton SO17 1BJ UK
| |
Collapse
|